Approximately 1.7 billion people worldwide are asymptomatically infected with Mycobacterium tuberculosis (Mtb). Co-infection with HIV dramatically increases the risk of developing active TB and constitutes a major impediment to global public health. Notably, there has been little basic research toward defining the mechanisms by which HIV modulates Mtb to enter, persist and emerge from a persistent state in the human tuberculous lung to cause active TB disease. We and others have recently discovered that carbon monoxide (CO), generated by heme oxygenase-1 (HO-1), is an Mtb dormancy signal and that HO-1 is necessary for granuloma formation. Further, it has been shown that HO-1 inhibits HIV replication. These findings suggest a key role for HO-1 in control of the TB/AIDS syndemic wherein HO-1 is key regulator of latency and reservoir maintenance. Our long-term goal is to understand the mechanisms by which HIV modulates TB latency and how these mechanisms can be manipulated for therapeutic and prophylactic purposes. The objective of this work is to generate a detailed, mechanistic understanding of the role of HO-1 and host bioenergetics in the context of TB and HIV infection. Our central hypothesis, based on substantial preliminary data, is that HIV causes an imbalance in the bioenergetic threshold of host cells, which is maintained by HO-1, to shift the balance from latent TB to an active infection. Our rationale is that the successful completion of this proposal will contribute missing, mechanistic elements of HO-1-dependent disease function to our base of knowledge, without which the mechanism of TB latency and HIV-mediated reactivation cannot be fully understood. We will apply novel techniques such as real-time metabolic flux analysis to non-invasively measure the oxygen consumption rate (OCR), extracellular acidification rate (ECAR), spare respiratory capacity (SRC), maximal respiration and ATP turnover of cells infected with Mtb and/or HIV. This powerful technology has not yet been applied to study the bioenergetics of bacterial/viral host interaction. We also will exploit novel HO-1 transgenic animals, and human TB lung tissue to accurately describe roles for HO-1 in TB/HIV in vivo. Further, we will examine the bioenergetic status of healthy, latent TB, active TB, TB/HIV and HIV-infected patients in South Africa. The research is innovative, in our opinion, because it represents a new and substantive departure from the status quo by applying novel technologies and unique patient cohorts to examine HO-1 and bioenergetics as paradigms to better understand TB/HIV disease. This contribution is significant because it is the first step in the continuum of TB/HIV research that will (i) provide in-depth mechanistic insight from a basic and clinical research point of view into the role of HO-1 in regulating HIV and Mtb disease, (ii) characterize the bioenergetic threshold of TB/HIV patients, and (iii) identify the Mtb/HIV co-infected cell populations and cellular events in human lung granulomas. Overall, these studies will provide a new basis for understanding TB and HIV persistence in the human tuberculous lung.

Public Health Relevance

Approximately 1.7 billion people worldwide are asymptomatically infected with Mycobacterium tuberculosis (Mtb), and HIV co-infection dramatically increases the risk of developing active TB. Our hypothesis is that HIV causes an imbalance in the bioenergetic threshold, maintained by heme oxygenase -1, to shift the balance from a latent TB to an active infection. Once it is known what HIV mechanisms modulate TB latency, they can likely be manipulated pharmacologically resulting in innovative approaches to the prevention and treatment of TB and/or HIV.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI111940-01A1
Application #
8898463
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Frank, Daniel J
Project Start
2015-04-20
Project End
2020-03-31
Budget Start
2015-04-20
Budget End
2016-03-31
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Cumming, Bridgette M; Addicott, Kelvin W; Adamson, John H et al. (2018) Mycobacterium tuberculosis induces decelerated bioenergetic metabolism in human macrophages. Elife 7:
Cumming, Bridgette M; Chinta, Krishna C; Reddy, Vineel P et al. (2018) Role of Ergothioneine in Microbial Physiology and Pathogenesis. Antioxid Redox Signal 28:431-444
Cumming, Bridgette M; Rahman, Md Aejazur; Lamprecht, Dirk A et al. (2017) Mycobacterium tuberculosis arrests host cycle at the G1/S transition to establish long term infection. PLoS Pathog 13:e1006389
Chinta, Krishna C; Saini, Vikram; Glasgow, Joel N et al. (2016) The emerging role of gasotransmitters in the pathogenesis of tuberculosis. Nitric Oxide 59:28-41